ID28791A - DEHYDROGENASE HYDROCISTEROID 3α TYPE 3 - Google Patents
DEHYDROGENASE HYDROCISTEROID 3α TYPE 3Info
- Publication number
- ID28791A ID28791A IDW20010531A ID20010531A ID28791A ID 28791 A ID28791 A ID 28791A ID W20010531 A IDW20010531 A ID W20010531A ID 20010531 A ID20010531 A ID 20010531A ID 28791 A ID28791 A ID 28791A
- Authority
- ID
- Indonesia
- Prior art keywords
- hydrocisteroid
- dehydrogenase
- type
- dehydrogenase hydrocisteroid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US9562398P | 1998-08-07 | 1998-08-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
ID28791A true ID28791A (en) | 2001-07-05 |
Family
ID=22252842
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IDW20010531A ID28791A (en) | 1998-08-07 | 1999-08-06 | DEHYDROGENASE HYDROCISTEROID 3α TYPE 3 |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1102582A2 (en) |
JP (1) | JP2002522380A (en) |
CN (1) | CN1322130A (en) |
AR (1) | AR021757A1 (en) |
AU (1) | AU5144999A (en) |
CA (1) | CA2339368A1 (en) |
ID (1) | ID28791A (en) |
NO (1) | NO20010651L (en) |
WO (1) | WO2000007576A2 (en) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5504074A (en) | 1993-08-06 | 1996-04-02 | Children's Medical Center Corporation | Estrogenic compounds as anti-angiogenic agents |
US6908910B2 (en) | 1993-08-06 | 2005-06-21 | The Children's Medical Center Corporation | Estrogenic compounds as anti-mitotic agents |
EP1321146A3 (en) * | 1998-03-11 | 2004-06-02 | Endorecherche Inc. | Inhibitors of type 5 and 3 17beta-hydroxysteroid dehydrogenase and methods for their use |
US7087592B1 (en) | 1999-08-23 | 2006-08-08 | Entre Med, Inc. | Compositions comprising purified 2-methoxyestradiol and methods of producing same |
US6891953B1 (en) | 2000-06-27 | 2005-05-10 | Microsoft Corporation | Method and system for binding enhanced software features to a persona |
US7135581B2 (en) | 2000-08-18 | 2006-11-14 | Entremed, Inc. | Antiangiogenic agents |
US6995278B2 (en) * | 2000-08-18 | 2006-02-07 | Entre Med, Inc. | Antiangiogenic agents |
AU2001288386B2 (en) * | 2000-11-27 | 2006-11-02 | Entremed, Inc. | 2-substituted estrogens as antiangiogenic agents |
US6710037B2 (en) * | 2001-05-01 | 2004-03-23 | Schering Corporation | Method of treating androgen-dependent disorders |
WO2003015820A1 (en) * | 2001-08-10 | 2003-02-27 | Takeda Chemical Industries, Ltd. | GnRH AGONIST COMBINATION DRUGS |
US7524866B2 (en) | 2001-11-29 | 2009-04-28 | Gtx, Inc. | Prevention and treatment of androgen—deprivation induced osteoporosis |
MXPA04005112A (en) * | 2001-11-29 | 2005-04-29 | Gtx Inc | Prevention and treatment of androgen-deprivation induced osteoporosis. |
JP2007529426A (en) | 2004-03-12 | 2007-10-25 | エントレメッド インコーポレイテッド | Anti-angiogenic drugs |
DE102004032674A1 (en) * | 2004-07-02 | 2006-01-26 | Schering Ag | New 2-substituted Estra-1,3,5 (10) -triene-17-ones as inhibitors of 17β-hydroxysteroid dehydrogenase type 1 |
US7419972B2 (en) | 2004-07-02 | 2008-09-02 | Schering Ag | 2-substituted estra-1,3,5(10)-trien-17-ones as inhibitors of 17β-hydroxy steroid dehydrogenase type 1 |
EP2001482B1 (en) | 2006-03-20 | 2016-08-24 | CASI Pharmaceuticals, Inc. | Disease modifying anti-arthritic activity of 2-methoxyestradiol |
US9284345B2 (en) | 2007-04-12 | 2016-03-15 | Endorecherche, Inc. | 17alpha-substituted steroids as systemic antiandrogens and selective androgen receptor modulators |
US8513422B2 (en) * | 2007-08-31 | 2013-08-20 | Astellas Pharma Inc. | Piperidine derivative |
CN101698834B (en) * | 2009-09-08 | 2012-05-23 | 北京利德曼生化股份有限公司 | 3 alpha-hydroxysteroid dehydrogenase, nucleotide sequence thereof, recombinant vector thereof, recombinant host cells thereof and kit |
WO2014009274A1 (en) * | 2012-07-10 | 2014-01-16 | Bayer Pharma Aktiengesellschaft | 3-substituted estra-1,3,5(10),16-tetraene derivatives, methods for the production thereof, pharmaceutical preparations containing same, and use thereof for the production of medicaments |
US9714266B2 (en) * | 2013-02-21 | 2017-07-25 | Bayer Pharma Aktiengesellschaft | Estra-1,3,5(10),16-tetraene-3-carboxamides for inhibition of 17.beta.-hydroxysteroid dehydrogenase (AKR1C3) |
CN104873520A (en) * | 2014-02-27 | 2015-09-02 | 天津药物研究院 | 11 beta-hydroxysteroid dehydrogenase inhibitor and its pharmaceutical composition and use |
CN104873525A (en) * | 2014-02-27 | 2015-09-02 | 天津药物研究院 | 11 beta-hydroxysteroid dehydrogenase inhibitor and its pharmaceutical composition and use |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3562260A (en) * | 1965-08-23 | 1971-02-09 | Ormonoterapia Richter Spa | 2-carbonyl-estratrienes and method of their preparation |
US4340602A (en) * | 1978-10-18 | 1982-07-20 | Wayne State University | Compositions inhibiting estrogen sulfotransferase activity |
JPS59157023A (en) * | 1983-02-22 | 1984-09-06 | ジヨウキム・ジヨ−ジ・リ−ル | Treatment for estrodiene deficiency |
US4568673A (en) * | 1984-03-20 | 1986-02-04 | Wayne State University | Compositions inhibiting murine MXT ductal carcinoma |
US5504074A (en) * | 1993-08-06 | 1996-04-02 | Children's Medical Center Corporation | Estrogenic compounds as anti-angiogenic agents |
US6541463B1 (en) * | 1998-03-11 | 2003-04-01 | Endorecherche, Inc. | Inhibitors of type 5 and type 3 17β-hydroxysteroid dehydrogenase and methods for their use |
-
1999
- 1999-08-06 EP EP99936218A patent/EP1102582A2/en not_active Withdrawn
- 1999-08-06 CN CN99811739A patent/CN1322130A/en active Pending
- 1999-08-06 AR ARP990103961A patent/AR021757A1/en unknown
- 1999-08-06 CA CA002339368A patent/CA2339368A1/en not_active Abandoned
- 1999-08-06 AU AU51449/99A patent/AU5144999A/en not_active Abandoned
- 1999-08-06 JP JP2000563261A patent/JP2002522380A/en active Pending
- 1999-08-06 WO PCT/CA1999/000724 patent/WO2000007576A2/en not_active Application Discontinuation
- 1999-08-06 ID IDW20010531A patent/ID28791A/en unknown
-
2001
- 2001-02-07 NO NO20010651A patent/NO20010651L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AR021757A1 (en) | 2002-08-07 |
WO2000007576A2 (en) | 2000-02-17 |
NO20010651D0 (en) | 2001-02-07 |
AU5144999A (en) | 2000-02-28 |
NO20010651L (en) | 2001-04-05 |
EP1102582A2 (en) | 2001-05-30 |
CA2339368A1 (en) | 2000-02-17 |
WO2000007576A3 (en) | 2000-03-30 |
CN1322130A (en) | 2001-11-14 |
JP2002522380A (en) | 2002-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ID28791A (en) | DEHYDROGENASE HYDROCISTEROID 3α TYPE 3 | |
DE69919953D1 (en) | FUNCTIONAL COMPOSITIONS | |
DE59902009D1 (en) | Schell arrangement | |
DE59908291D1 (en) | Metal complex pigments | |
ID23458A (en) | NEFAZODON AVAILABLE FORM | |
DE69908455D1 (en) | inserter | |
EE200000552A (en) | Demodulator | |
DE69942892D1 (en) | GAS-CREATING COMPOSITION | |
DE69905495D1 (en) | BISMUTHMANGANIT PIGMENTS | |
ID26909A (en) | DOWN 1,3,4-OKSADIAZOLON | |
DE69903507D1 (en) | pickling | |
DE69926606D1 (en) | PLAZENTAPROTEIN 13 | |
DE69932411D1 (en) | Digitaer demodulator | |
EE200000554A (en) | Demodulator | |
DE69901764D1 (en) | pickling | |
NO20003690D0 (en) | composting Toilet | |
DE69906234D1 (en) | gumming | |
DE69914990D1 (en) | Flat scoreboard | |
EE200000553A (en) | Demodulator | |
DE19833552B4 (en) | dashboard | |
DE69939964D1 (en) | Gel-shaped composition | |
ATA192798A (en) | Flagpole | |
KR19980059340U (en) | Crayon case | |
AT2526U3 (en) | COMPOST STARTER | |
FI981116A0 (en) | composter |